Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2024

Mar 14, 2024

31996_dirs_2024-03-14_c60b7b46-e77e-4b00-ab87-9d815e2450e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2024-03-12

Reporting Person: Jiang Wei (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-12 Common Stock A 1299 $0.00 Acquired 1299 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-12 Restricted Stock Units $0.00 A 1061 Acquired Common Stock (1061) Direct

Footnotes

F1: Effective March 12, 2024, the Board of Directors appointed Mr. Jiang to serve as a member of the Board and granted him, as a non-employee director, 1,299 restricted shares, which represents a pro-rated amount of the standard director equity compensation for a director serving during the 2023-2024 term. These restricted shares vest in full on the earlier of June 20, 2024, or the Corporation's 2024 Annual Meeting of Shareholders.

F2: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.

F3: RSUs granted as compensation for services as a director to non-employee directors who elected to receive shares in lieu of director cash
compensation fees. Mr. Jiang has elected to defer delivery of these shares.